미국 · 보도자료 · HIND · 2026-10-05 12:00
안구 염증 치료제 VT-1908 관련 미국 특허 등록 결정
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $HIND #ocularinflammation--Vyome Holdings, Inc. (Nasdaq: HIND) (“Vyome”), a clinical-stage biopharmaceutical company focused on immuno-inflammatory and rare disease conditions, today announced that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for U.S. Patent Application No. 17/787,303, titled “Formulations and Method
